NDC codes

FDA NDC Directory
Product NDC (as listed)60219-1425Labeler and product segments. Claims need a package NDC.
Product NDC at billing width60219-1425Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
60219-1425-5602191425056021914250550 FOR SOLUTION in 1 CARTON (60219-1425-5)Marketed from Dec 7, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Vigabatrin
Generic name (nonproprietary)
vigabatrin
Active ingredients
Vigabatrin — 500 mg/1
Dosage form
For solution
Route
Oral
Labeler
Amneal Pharmaceuticals NY LLCNDC labeler code 60219
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 210155
Marketing start
Listing expires
Identifiers
Product ID 60219-1425_3bf642d5-5597-4668-a4ab-d240699a395eSPL ID 3bf642d5-5597-4668-a4ab-d240699a395eSPL set ID 9791494f-492b-487a-8211-7747fb57923eRxCUI 250820UNII GR120KRT6KUPC 0360219142558, 0360219142510
Pharmacologic class
Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460219142505 followed by a unit qualifier and the quantity

Package 60219-1425-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Vigabatrin for oral solution is indicated for the treatment of: Refractory Complex Partial Seizures as adjunctive therapy in patients 2 years of age and older who have responded inadequately to several alternative treatments; vigabatrin for oral solution is not indicated as a first line agent. ( 1.1 ) Infantile Spasms - monotherapy in infants 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss. ( 1.2 ) 1.1 Refractory Complex Partial Seizures (CPS) Vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60219-1425

What is NDC 60219-1425?
60219-1425 is the product NDC for Vigabatrin, Vigabatrin 500 mg/1 for solution, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Vigabatrin.
What is the active ingredient?
Vigabatrin.
Who is the labeler?
Amneal Pharmaceuticals NY LLC, NDC labeler code 60219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vigabatrin?
16 other product NDCs are listed under this name. See all Vigabatrin NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Vigabatrin NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
vigabatrinVigabatrin 500 mg/1Tablet, Film coatedOralCarnegie Pharmaceuticals LLC80005-16780005-0167-11
vigabatrinVigabatrin 500 mg/10mLPowder, For solutionOralZydus Pharmaceuticals (USA) Inc.70710-149470710-1494-08
vigabatrinVigabatrin 500 mg/10mLPowder, For solutionOralZydus Lifesciences Limited70771-174270771-1742-08
VigabatrinVigabatrin 500 mg/1TabletOralHikma Pharmaceuticals USA Inc0054-065200054-0652-25
VigabatrinVigabatrin 50 mg/mLFor solutionOralNovadoz Pharmaceuticals LLC72205-09372205-0093-50
VigabatrinVigabatrin 500 mg/1TabletOralEdenbridge Pharmaceuticals LLC.42799-95042799-0950-01
VigabatrinVigabatrin 500 mg/1TabletOralAurobindo Pharma Limited59651-36759651-0367-01
vigabatrinVigabatrin 500 mg/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-128770710-1287-01
vigabatrinVigabatrin 500 mg/1Tablet, Film coatedOralZydus Lifesciences Limited70771-165470771-1654-01
VigabatrinVigabatrin 500 mg/1Powder, For solutionOralAurobindo Pharma Limited59651-36659651-0366-50

All 17 Vigabatrin NDCs

Other NDCs under ANDA 210155

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210155
ProductStrengthForm · routeLabelerProduct NDC
VigabatrinVigabatrin 500 mg/1For solutionOralAmneal Pharmaceuticals NY LLC69238-1425

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in